Search results
Bain Capital-backed Emcure Pharma to float IPO on July 3
The Economic Times· 5 days agoEmcure Pharmaceuticals, backed by Bain Capital, is set to launch its IPO on July 3. The IPO includes...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 1 day agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Sattva group, Bain Capital to float platform to build co-living assets
The Hindu· 6 days agoBengaluru-based Sattva group is on the verge of signing an agreement with Bain Capital to set up a platform that would develop built-to-suit assets that ...
Emcure Pharma IPO To Open On July 3: All You Need To Know - News18
News18· 17 hours agoEmcure Pharm IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by Bain...
Vraj Iron and Steel IPO allotment today. Latest GMP, steps to check allotment status online, other...
Livemint· 20 hours agoVraj Iron and Steel IPO allotment status can be checked online through the website of BSE and on the...
Qatar Airways looking to buy up to 20% stake in Virgin Australia, says report
VCCircle· 5 days agoQatar Airways is in talks to buy up to a 20% stake in Bain Capital-owned Virgin Australia, the...
Qatar Airways in talks to acquire 20% stake in Virgin Australia
CNBC Awaaz· 5 days agoNegotiations between Qatar Airways and Virgin Australia’s owner,Bain Capital, may still take some...
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 14 hours agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on...
M&A deal value slows down by 9% to $38 billion in first half of 2024
Business Standard India· 11 hours agoM&A deal value down: Deals to pick up in the second half, say bankers
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO - The Economic Times
The Economic Times· 15 hours agoShark Tank fame Namita Thapar, part of the promoter group of Emcure Pharmaceuticals, will make...